Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCN
3926
Waste Connections
WCN
$41.8B
| $2.55M | ﹤0.01% |
26,643
-15,850
| -37% | -$1.46M |
|
3927
PUT
EPAM Systems
EPAM
$5.18B
| $2.54M | ﹤0.01% |
14,700
-1,100
| -7% | -$189K |
|
3928
CALL
Universal Health Services
UHS
$10B
| $2.54M | ﹤0.01% |
19,500
-900
| -4% | -$113K |
|
|
WUBA
3929
PUT
DELISTED
58.com Inc
WUBA
| $2.54M | ﹤0.01% |
40,900
-7,000
| -15% | -$451K |
|
3930
CALL
iShares MSCI Germany ETF
EWG
$1.68B
| $2.54M | ﹤0.01% |
90,500
-51,100
| -36% | -$1.43M |
|
3931
CALL
SM Energy
SM
$8.03B
| $2.54M | ﹤0.01% |
202,800
+39,700
| +24% | +$576K |
|
3932
CALL
Landstar System
LSTR
$6.45B
| $2.54M | ﹤0.01% |
23,500
+8,700
| +59% | +$928K |
|
3933
Stryker
SYK
$130B
| $2.54M | ﹤0.01% |
12,340
-330,352
| -96% | -$63.1M |
|
3934
PUT
Dover
DOV
$27.9B
| $2.54M | ﹤0.01% |
25,300
-10,300
| -29% | -$988K |
|
3935
CALL
Nice
NICE
$5.99B
| $2.54M | ﹤0.01% |
18,500
+9,500
| +106% | +$1.28M |
|
3936
iShares MSCI Mexico ETF
EWW
$1.86B
| $2.53M | ﹤0.01% |
58,422
-121,694
| -68% | -$5.46M |
|
3937
Enterprise Financial Services Corp
EFSC
$2.4B
| $2.53M | ﹤0.01% |
60,879
-11,018
| -15% | -$461K |
|
3938
Atkore
ATKR
$3.17B
| $2.53M | ﹤0.01% |
97,757
-220,006
| -69% | -$5.37M |
|
3939
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
| $2.53M | ﹤0.01% |
22,523
-28,166
| -56% | -$3.12M |
|
3940
Ecolab
ECL
$77.4B
| $2.53M | ﹤0.01% |
12,804
+3,749
| +41% | +$697K |
|
|
LKFT
3941
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $2.53M | ﹤0.01% |
19,600
-12,800
| -40% | -$1.52M |
|
|
MRO
3942
DELISTED
Marathon Oil Corporation
MRO
| $2.53M | ﹤0.01% |
177,818
-2,724,699
| -94% | -$42.1M |
|
|
KRTX
3943
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.52M | ﹤0.01% |
+125,998
| New | +$2.52M |
|
|
ICPT
3944
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.52M | ﹤0.01% |
31,700
-240,500
| -88% | -$21.5M |
|
3945
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.76B
| $2.52M | ﹤0.01% |
+47,658
| New | +$2.5M |
|
|
SAVE
3946
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.52M | ﹤0.01% |
52,800
+15,900
| +43% | +$810K |
|
3947
Nordson
NDSN
$17.2B
| $2.51M | ﹤0.01% |
17,780
+11,215
| +171% | +$1.54M |
|
|
QVCGA
3948
DELISTED
QVC Group Inc Series A
QVCGA
| $2.51M | ﹤0.01% |
4,178
-4,649
| -53% | -$3.31M |
|
|
PFPT
3949
PUT
DELISTED
Proofpoint, Inc.
PFPT
| $2.51M | ﹤0.01% |
20,900
-10,000
| -32% | -$1.18M |
|
3950
CALL
ManpowerGroup
MAN
$2.71B
| $2.51M | ﹤0.01% |
26,000
-73,700
| -74% | -$6.71M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.